Indian drugmaker Dr Reddy’s gets Brazil regulator nod to sell generic Ozempic
Nov 5 (Reuters) – Indian drugmaker Dr Reddy’s Laboratories said on Thursday it had received regulatory approval in Brazil to market and sell a generic version of Novo Nordisk’s blockbuster diabetes drug Ozempic. • Brazil has 16.6 million adults aged between 20 and 79 living with…